← Leaderboards
Robert William Baloh
University Of California Los Angeles
$5,482,156
Attributed
$7,081,594
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–18$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$14,560,237 · 7
By mechanism
P50$7,478,643 · 3
U01$3,198,876 · 1
R01$3,175,523 · 1
P01$706,852 · 1
M01$343 · 1
Top collaborators
- Jeffrey Paul Staab5 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Akira None Ishiyama$10,159,545
- Carla M. Koehler$14,340,942
- Jeffrey Paul Staab$1,599,438
- Amynah Amir Ali Pradhan$7,730,866
- Kevin Christopher Brennan$11,140,769
Others in their field
Top investigators on “Vertigo”
- Jonathan L. Haines · Doheny Eye Institute$6,595,774
- Stephen L Hauser · University Of California San Francisco$6,403,835
- Charles C Della Santina · Johns Hopkins University$6,070,463
- Alan Gi-Lun Cheng · Stanford University$5,849,589
- David E Newman-Toker · Johns Hopkins University$5,746,467
- Kevin Anthony Kerber · University Of Michigan At Ann Arbor$5,363,859
Research focus
VertigoHuman SubjectPatient Oriented ResearchLabyrinthBalancePostmortemVestibuloocular ReflexNervous System Disorder DiagnosisDiagnosis Design /EvaluationHistopathologyClinical ResearchAgingPrevalencePathologic ProcessDisease /Disorder EtiologyTemporal BoneMagnetic Resonance ImagingDiagnosisBrain Imaging /Visualization /ScanningNatural HistoryGaitLongitudinal Human StudyHuman Old Age (65+)Bioimaging /Biomedical Imaging
Grant awards (22)
A Phase II Trial on Rizatriptan for Vestibular Migraine$637,163
U01 · FY2018 · DC · contact PI
A Phase II Trial on Rizatriptan for Vestibular Migraine$636,532
U01 · FY2017 · DC · contact PI
A Phase II Trial on Rizatriptan for Vestibular Migraine$636,532
U01 · FY2016 · DC · contact PI
A Phase II Trial on Rizatriptan for Vestibular Migraine$630,165
U01 · FY2015 · DC · contact PI
A Phase II Trial on Rizatriptan for Vestibular Migraine$658,484
U01 · FY2014 · DC · contact PI
EPISODIC ATAXIA: GENOTYPE-PHENOTYPE CORRELATION AND NATURAL HISTORY STUDY$343
M01 · FY2007 · RR · contact PI
Diseases of the Vestibular System$1,559,181
P50 · FY2006 · DC · contact PI
DIZZINESS IN OLDER PEOPLE$50,000
R01 · FY2006 · AG · contact PI
Diseases of the Vestibular System$1,550,203
P50 · FY2005 · DC
DIZZINESS IN OLDER PEOPLE$539,539
R01 · FY2005 · AG
Diseases of the Vestibular System$1,505,058
P50 · FY2004 · DC
DIZZINESS IN OLDER PEOPLE$531,331
R01 · FY2004 · AG
Diseases of the Vestibular System$1,461,219
P50 · FY2003 · DC
DIZZINESS IN OLDER PEOPLE$523,447
R01 · FY2003 · AG
Diseases of the Vestibular System$1,402,982
P50 · FY2002 · DC
DIZZINESS IN OLDER PEOPLE$627,459
R01 · FY2002 · AG
CORE--CLINICAL COORDINATION/DATABASE MANAGEMENT$0
P50 · FY2002 · DC
GENETIC &MOLECULAR MECHANISMS OF EPISODIC VERTIGO$0
P50 · FY2002 · DC
DIZZINESS IN OLDER PEOPLE$486,762
R01 · FY2001 · AG
PATHOPHYSIOLOGY OF VESTIBULAR DISORDERS$353,426
P01 · FY2001 · DC
DIZZINESS IN OLDER PEOPLE$416,985
R01 · FY2000 · AG
PATHOPHYSIOLOGY OF VESTIBULAR DISORDERS$353,426
P01 · FY2000 · DC